Karin Kleinhans
Private Equity Investor at Merck Research Ventures
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrea Röhm | F | - |
EQT Partners GmbH
| 7 years |
| Robert Loos | M | - |
EQT Partners GmbH
| 8 years |
| Patrick Jaslowitzer | M | - |
EQT Partners GmbH
| 8 years |
| Marc-Alexander Straubinger | M | - |
EQT Partners GmbH
| 8 years |
| Nathalie Kaeser | F | - |
EQT Partners GmbH
| 6 years |
| Christian Horn | M | - |
EQT Partners GmbH
| 9 years |
| Pascal Noël | M | - |
EQT Partners GmbH
| 8 years |
| Simon Tillmo | M | 33 |
EQT Partners GmbH
| 9 years |
| Charlotte Keinhorst | F | - |
EQT Partners GmbH
| 4 years |
| Sascha Steck | M | - |
EQT Partners GmbH
| 4 years |
| Gebhard Littich | M | - |
EQT Partners GmbH
| 7 years |
| Stephanie Burger | F | - |
EQT Partners GmbH
| 4 years |
| Swen Schlegel | M | - |
EQT Partners GmbH
| 5 years |
| Jannis Gerweck | M | - |
EQT Partners GmbH
| 9 years |
| Deborah Fleischer | F | - |
EQT Partners GmbH
| 3 years |
| Philipp R. Wörner | M | - |
EQT Partners GmbH
| 7 years |
| Felix Heesch | M | - |
EQT Partners GmbH
| 6 years |
| Russell Greig | M | 71 |
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | 2 years |
| Fiona van Limburg Stirum | F | - |
EQT Partners GmbH
| 7 years |
| Christian Wolf | M | - |
EQT Partners GmbH
| 7 years |
| Philipp R. Woerner | M | - |
EQT Partners GmbH
| 7 years |
| Christian Küpper | M | - |
EQT Partners GmbH
| 8 years |
| Wolfgang Haaf | M | - |
EQT Partners GmbH
| 7 years |
| Vincenz Borrmann | M | - |
EQT Partners GmbH
| 8 years |
| Peter Dudek | M | - |
Merck Research Ventures
 Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | 6 years |
| Tobias Küng | M | - |
EQT Partners GmbH
| 9 years |
| Valentin Fliess | M | - |
EQT Partners GmbH
| 5 years |
| Florian Funk | M | - |
EQT Partners GmbH
| 7 years |
| Isabel De Paoli | F | - |
EQT Partners GmbH
| 3 years |
| Sebastian Lorenz | M | - |
EQT Partners GmbH
| 6 years |
| Andreas Niederle | M | - |
EQT Partners GmbH
| 5 years |
| Adrian Lüthge | M | - |
EQT Partners GmbH
| 6 years |
| Isabel de Paoli | F | 50 |
EQT Partners GmbH
| 3 years |
| Jan Stypulkowski | M | - |
EQT Partners GmbH
| 8 years |
| Christoph Broja | M | - |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | 2 years |
| Michael Bolter | M | - |
EQT Partners GmbH
| 5 years |
| Danilchanka Olga | M | - |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | 6 years |
| Bettina Siempelkamp | F | - |
EQT Partners GmbH
| 6 years |
| Fabian Frank | M | - |
EQT Partners GmbH
| 8 years |
| Jason R. Ruth | M | 39 |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | - |
| Stefan Oelrich | M | 56 |
Berlin Institute of Health
| 8 years |
| Thomas Soloway | M | 55 |
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | 3 years |
| Orly Vardeny | M | - |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jörg Neermann | M | 57 |
LSP Services Deutschland GmbH
| 11 years |
| Felix Burgdorf | M | - |
EQT Partners GmbH
| 5 years |
| Thomas Klews | M | - |
EQT Partners GmbH
| 10 years |
| Martin Mix | M | - |
EQT Partners GmbH
| - |
| Fabian Mohr | M | - |
Universität Ulm
| 6 years |
| Fee-Debora Blum | F | - |
EQT Partners GmbH
| - |
| Max Thielemann | M | - |
EQT Partners GmbH
| - |
| Nicolas Kollmann | M | - |
EQT Partners GmbH
| - |
| Alexis Tran Viet | M | - |
EQT Partners GmbH
| 6 years |
| Sebastian Reinartz | M | - |
EQT Partners GmbH
| 3 years |
| Michael C. Hammer | M | - |
Universität Ulm
| 4 years |
| Alice Strecker | F | - |
EQT Partners GmbH
| 2 years |
| Elvan Karatas | F | - |
EQT Partners GmbH
| 2 years |
| Basile Hayez | M | - |
EQT Partners GmbH
| 1 years |
| Kai Andrejewski | M | 57 |
Universität Ulm
| 3 years |
| Jovana Zavisin | F | - |
Universität Ulm
| 3 years |
| Jan Van den Bossche | M | - |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | 1 years |
| Amrita Jain | M | - |
LSP Services Deutschland GmbH
| 1 years |
| Hajo Krösche | M | - |
EQT Partners GmbH
| 7 years |
| Matteo Thun | M | - |
EQT Partners GmbH
| 7 years |
| Nils Ketter | M | - |
EQT Partners GmbH
| 10 years |
| Sabrina Flunkert | F | - |
EQT Partners GmbH
| 5 years |
| Ralph Betz | M | - |
EQT Partners GmbH
| 6 years |
| Martin Adam | M | - |
EQT Partners GmbH
| 2 years |
| Reza Halse | M | 50 |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | 4 years |
| Christine Brennan | M | 56 |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | 5 years |
| Thomas Joachim Hansen | M | - |
EQT Partners GmbH
| 2 years |
| Arno Poschik | M | - |
EQT Partners GmbH
| - |
| Päivi Arminen | F | 46 |
EQT Partners GmbH
| 2 years |
| Annette Koehler | M | 57 |
Universität Ulm
| 4 years |
| Ertugrul Sönmez | M | - |
Universität Ulm
| 3 years |
| Stephan Leithner | M | 58 |
EQT Partners GmbH
| 2 years |
| Daniel Pindur | M | 46 |
Universität Ulm
| 3 years |
| Daniel Monch | M | 38 |
Universität Ulm
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 72 | 93.51% |
| United States | 5 | 6.49% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karin Kleinhans
- Personal Network
